Searchable abstracts of presentations at key conferences in endocrinology

ea0024p7 | (1) | BSPED2010

Glucocorticoid hypofunction in Myotonic Dystrophy

Anand G , McHale E , Ray N , McShane M A , Ryan F J

Myotonic Dystrophy is an autosomal dominant multi-system disorder characterised by muscle weakness and myotonia, with associated cardiac, ophthalmic, gastrointestinal and endocrine abnormalitiesA 16-year-old boy was referred with a 2 months history of difficulty releasing his hand-grip and problems with swallowing. The clinical diagnosis of myotonic dystrophy 1 was confirmed with genetic testing with the detection of a DMPK expansion mutation. During inv...

ea0024p50 | (1) | BSPED2010

Why the confusion in Hashimoto’s encephalopathy?

Anand G , Jayasekara A , Ibitoye R , Ray N , McShane M A , Ryan F J

Neurological complications of thyroid disease are well recognised; however the distinct clinical entity of encephalopathy associated with autoimmune thyroid disease has been only occasionally reported in the paediatric population. We describe a case of Hashimoto’s encephalopathy (HE) in a teenage girl.A 13-year-old girl presented with seizures and prolonged confusion. Baseline blood tests, CSF analysis and CT Brain were essentially normal. She was d...

ea0011p3 | Bone | ECE2006

The effect of local radiotherapy on osteoprotegrin levels in patients with bone metastases

Abdulkhaliq A , Foo C , Baffoe G , Anand P , Girgis SI , Quigley C

Pain due to bone metastases can be relieved by local radiotherapy (RT). The mechanism of pain relief by RT has not been fully elucidated. Inhibition of bone resorption has been proposed as a possible mechanism. Osteoprotegrin (OPG) has been shown to block behaviours indicative of pain in mice with bone metastases and to diminish bone destruction (Honore et al., 2000, Nature Medicine 6; 521–8).The aim of this study was to evaluate serum OPG le...